Amylyx
AMLX

Amylyx (AMLX) analyst forecast and price target

Analyst forecast

Buy

Consensus of 12 analyst ratings

Buy
11
Hold
1
Sell
0
Average price target
$46.40+39.76% vs. last price
Last $33.20
Low $26.00High $57.00

Based on 5 analyst targets

Recent analyst ratings

FirmActionRatingPrice targetDate
GuggenheimMaintainedBuy$57.00 from $55.00Aug 27, 2026
BairdMaintainedOutperform$52.00 from $28.00Aug 19, 2026
GuggenheimMaintainedBuy$55.00 from $40.00Aug 19, 2026
MizuhoMaintainedOutperform$42.00 from $30.00Aug 19, 2026
HC Wainwright & Co.MaintainedBuy$55.00 from $34.00Aug 18, 2026
MizuhoMaintainedOutperform$30.00 from $24.00Aug 17, 2026
CitigroupMaintainedBuy$26.00 from $20.00Aug 3, 2026
MizuhoMaintainedOutperform$24.00 from $21.00Jul 20, 2026
GuggenheimMaintainedBuy$40.00 from $30.00Jun 25, 2026
MizuhoMaintainedOutperform$21.00 from $19.00Apr 28, 2026
HC Wainwright & Co.MaintainedBuy$34.00Mar 25, 2026
GuggenheimMaintainedBuy$30.00 from $25.00Mar 19, 2026
HC Wainwright & Co.MaintainedBuy$34.00 from $28.00Mar 4, 2026
StifelInitiated CoverageBuy$21.00Mar 3, 2026
B of A SecuritiesMaintainedBuy$19.00 from $15.00Feb 20, 2026
HC Wainwright & Co.MaintainedBuy$28.00 from $20.00Feb 10, 2026
HC Wainwright & Co.MaintainedBuy$20.00 from $16.00Nov 7, 2025
CitigroupMaintainedBuy$20.00 from $12.00Oct 17, 2025
BairdMaintainedOutperform$19.00 from $10.00Oct 16, 2025
B of A SecuritiesMaintainedBuy$16.00 from $14.00Oct 3, 2025

Frequently asked questions

  • What is the price target for AMLX stock?

    The average 12-month analyst price target for Amylyx (AMLX) is $46.40, with a high estimate of $57.00 and a low of $26.00, across 5 analysts.

  • Is AMLX a buy, sell, or hold?

    Analysts covering Amylyx currently average a Buy rating: 11 buy, 1 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

  • What upside do analysts see for AMLX?

    The average price target of $46.40 implies 39.76% upside from the last price of $33.20.

  • What is the latest analyst rating on AMLX?

    On Aug 27, 2026, Guggenheim maintained Amylyx at Buy with a price target of $57.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.